Clinical Trial Update: B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update describing B7H3-targeted CAR T-cell therapy for recurrent/refractory pediatric solid tumors, including several sarcoma subtypes an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Hepatoblastoma
• Neuroblastoma
• Osteosarcoma
• Retinoblastoma
• Rhabdomyosarcoma
• Soft Tissue Sarcoma
• Wilms Tumor

Drugs mentioned

• B7H3 CAR T cells (B7H3-targeted CAR T cells)

Snippet

Sponsor: Seattle Children's Hospital | Conditions: Pediatric Solid Tumor, Germ Cell Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING